After assessing the safety of the medicine, Maldives Food and Drug Authority (MFDA) has reissued permission for the usage of Panadol medicine today.
In the alert released by the Authority, it was disclosed that the results of the investigation conducted into quality fluctuation of the 500 milligram Panadol medicine has been received. MDFA has shared that the report had revealed an absence of the appropriate strength required in the “Panadol” brand.